Bioinformatics News Jul 2007: bioinformatics, genomics, proteomics, microarray, etc.

Previous 1 2 3 4 Next

XDx Selects Ingenuity Systems IPA 5.0 for Pathways Solution
Ingenuity Systems, the leading provider of solutions to explore, analyze, and interpret scientific literature and data, today announced that XDx, a leading molecular diagnostics company, has licensed Ingenuity's flagship solution IPA 5.0. Ingenuity Systems was selected by XDx after a comprehensive evaluation of several pathway analysis products. (Tue, 10 Jul 2007 10:52:08 GMT)

Scientists Establish Essential Markers to Characterize Human Embryonic Stem Cell Lines
SHEFFIELD, England & FOSTER CITY, Calif.----Scientists with the International Stem Cell Initiative have identified a set of common gene expression markers that may be used to reliably characterize diverse human embryonic stem cell lines. (Tue, 10 Jul 2007 11:00:00 GMT)

UB assembles impressive team to help develop new master plan
The University at Buffalo has awarded $4.5 million worth of contracts to a team of wellknown architects and planners that will help redesign UB’s campuses for future growth, the university announced Monday. (Tue, 10 Jul 2007 11:01:41 GMT)

Expression Analysis Enters Agreement With GeneGo to Provide Functional Analysis Services Using 1-2-3 Workflow
GeneGo, Inc., the leading systems biology tools company, announced today that Expression Analysis, Inc. will be providing functional analysis (pathways and networks) add-on services to their customers. Expression Analysis is the leading microarray services and solutions provider for clinical trials customers. GeneGo's "1-2-3 Workflow" automatically uploads and normalizes genomics data, compares ... (Tue, 10 Jul 2007 11:54:14 GMT)

'Virtual' mouse brains for practice
WASHINGTON: A multi-institutional consortium that includes Duke University has created high resolution, three-dimentional microscopic images of tiny mouse brains, which unveil every layer of the organ. (Tue, 10 Jul 2007 12:02:13 GMT)

Safeguard Scientifics Leads $8.7 Million Series B Financing for Cellumen, Inc.
WAYNE, Pa.----Safeguard Scientifics, Inc. , a holding company that builds value in growth-stage technology and life sciences companies, today announced an $8.7 million Series B financing for Cellumen, Inc., a cellular systems biology company, of which Safeguard provided $6 million. (Tue, 10 Jul 2007 13:00:00 GMT)

Luminex and Exiqon Sign Distribution Agreement for MicroRNA Products and Launch Expanded Product Line
Luminex Corporation , a leading provider of multiplex solutions, and Exiqon A/S , a leading supplier of high-value gene expression analysis products, today announced the execution of a distribution agreement for the FlexmiR line of products co-developed by the companies in 2006. (Tue, 10 Jul 2007 14:30:00 GMT)

Luminex and Exiqon Sign Distribution Agreement for MicroRNA Products and Launch Expanded Product Line
Luminex Corporation , a leading provider of multiplex solutions, and Exiqon A/S (OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced the execution of a distribution agreement for the FlexmiR(TM) line of products co-developed by the companies in 2006. Under the terms of the agreement, Exiqon has obtained non-exclusive rights to distribute current and new ... (Tue, 10 Jul 2007 15:08:13 GMT)

Mexico Genomics Initiative to use Illumina's BeadStation in SNP, Gene-Expression Studies
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 10 Jul 2007 15:59:34 GMT)

Now, 'virtual' mouse brains available on the net
Washington, July 10 : A multi-institutional consortium that includes Duke University has created high resolution, three-dimentional microscopic images of tiny mouse brains, which unveil every layer of the organ. (Tue, 10 Jul 2007 17:20:31 GMT)

Invitrogen Develops Prototype Hand-Held Biothreat Detectors under $3.9M Contract from Defense Threat Reduction Agency
CARLSBAD, Calif.----Invitrogen Corporation , a provider of essential life science technologies for disease research and drug discovery, today announced that its subsidiary, Invitrogen Federal Systems, under a $3.9 million contract from the Defense Threat Reduction Agency , successfully completed the development of a prototype hand-held device for the detection of multiple biothreat agents in a ... (Tue, 10 Jul 2007 21:00:00 GMT)

Recanati wants more state money to go to science education
Leon Recanati is worried about the level of education in Israel, so worried that he has broken his self-imposed media silence since his sale of IDB Holding Corp. about four years ago. In an interview with TheMarker, Recanati calls on the government to treat education more seriously. (Tue, 10 Jul 2007 22:20:19 GMT)

Breast cancers to be more aggressive in African-American women
A study of more than 2,200 women at the Kimmel Cancer Center at Jefferson in Philadelphia shows that African American women have more advanced breast cancer at the time of diagnosis than Caucasian women. (Tue, 10 Jul 2007 23:54:37 GMT)

3-D microscopic views of tiny mouse brains available online
A multi-institutional consortium including Duke University has created startlingly crisp 3-D microscopic views of tiny mouse brains - unveiled layer by layer - by extending the capabilities of conventional magnetic resonance imaging. (Wed, 11 Jul 2007 00:10:04 GMT)

Gift wrap lingerie
A novel type of lingerie garment that wraps around a person to create a bow shaped design across the person's chest area to give the appearance that the person wearing the garment has been gift wrapped. When being (Wed, 11 Jul 2007 05:15:49 GMT)

Korean Research Institute of Bioscience and Biotechnology Licenses ERGO(TM) Genomics Platform to Identify Biological ...
Korean research Institute of Bioscience and Biotechnology (KRIBB), a world leader in the integrated biotechnology and bioinformatics has licensed the ERGO(TM) bioinformatics software developed and maintained by Integrated Genomics. KRIBB will utilize the ERGO(TM) genome analysis tools for gene annotation, metabolic reconstruction and enzyme data-mining as well as for comparative genomics purposes. (Wed, 11 Jul 2007 05:48:00 GMT)

Canadian, British And American Scientists Launch Major New Genome Partnership To Catalogue All Common Copy Number ...
An international team will use state-of-the-art, high-density microarrays and new computer algorithms to improve the detection of variants in the human genome which are implicated in various diseases. The new systems are the foundation of Phase 2 of the Genome Structural Variation Consortium, which was set up in 2004 and seeks to identify structurally variable regions in the human genome. [click ... (Wed, 11 Jul 2007 08:16:57 GMT)

Synthetic Genomics Inc. and Asiatic Centre for Genome Technology Form Partnership to Sequence Oil Palm Genome
Synthetic Genomics Inc., a privately-held company dedicated to commercializing synthetic genomic processes and naturally occurring processes for alternative energy solutions, and Asiatic Centre for Genome Technology Sdn Bhd , a center that focuses on the application of genome technology to improve oil palm and other crops, today announced a multi-year, research and development joint venture to ... (Wed, 11 Jul 2007 09:00:00 GMT)

CODA Genomics Announces Series C Financing
CODA Genomics, Inc., a pioneer in applying Translation Engineering towards challenging protein expression, today announced it has secured $7 million in Series C financing. The Company will use these funds to expand and manage the growth experienced by the Company, driven primarily by the success of new and expanding collaborations with pharmaceutical and biopharmaceutical companies. (Wed, 11 Jul 2007 10:00:00 GMT)

Acacia Technologies Licenses Credit Card Fraud Protection Technology to SAP
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that Financial Systems Innovation LLC, a wholly owned subsidiary of the Acacia Technologies group settled a potential dispute involving U.S. (Wed, 11 Jul 2007 10:00:00 GMT)

Countdown to a synthetic lifeform
As the first genome "transplant" is performed, scientists say it is only a matter of time before a truly artificial lifeform is created (Wed, 11 Jul 2007 10:23:48 GMT)

EntreMed to Collaborate with University of New South Wales on Panzem(R) Mechanisms
EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics primarily for the treatment of cancer and inflammatory diseases, announced that it has entered into a collaborative research agreement with the University of New South Wales and Children's Cancer Institute Australia for Medical Research to map pathways involved in the mechanism of action for its lead compound, ... (Wed, 11 Jul 2007 11:00:00 GMT)

Expanded Applications In Bioscience And Open Vessel Reactions Highlight 5th International Microwaves In Chemistry ...
New research in bioscience applications and the expanded use of microwave-assisted open vessel reactions highlighted the 5th International Microwaves in Chemistry Conference. The conference, which was held April 18-20, 2007 at Imperial College in London, was the largest to date with 250 attendees and more than 40 poster presentations (Wed, 11 Jul 2007 11:04:38 GMT)

Acacia Technologies Licenses Credit Card Fraud Protection Technology to SAP
NEWPORT BEACH, Calif., (Wed, 11 Jul 2007 11:23:30 GMT)

Thallion Announces Closing of Sale of Majority Stake in Caprion Proteomics to Great Point Partners
Thallion Pharmaceuticals Inc. today announced that it has closed the previously announced sale of an 80 percent stake in the Company's wholly-owned proteomics business, Caprion Proteomics GP, to a company formed by Great Point Partners, LLC of Greenwich, Connecticut. (Wed, 11 Jul 2007 11:30:00 GMT)

Nanogen Gains Access to Schizophrenia Markers
SAN DIEGO----Nanogen, Inc. , developer of advanced diagnostic products, announced today that it has entered into an agreement whereby the company acquired rights to genetic markers related to schizophrenia and responses to antipsychotic therapies. (Wed, 11 Jul 2007 12:00:00 GMT)

Breast Cancers More Aggressive In African-American Women, Early Breast Cancer Screening Recommended By Oncologists
A study of more than 2,200 women at the Kimmel Cancer Center at Jefferson in Philadelphia shows that African American women have more advanced breast cancer at the time of diagnosis than Caucasian women. In addition, African American women tend to have breast cancer tumor types that are more aggressive and have poorer prognoses. [click link for full article] (Wed, 11 Jul 2007 12:11:08 GMT)

Thallion Announces Closing of Sale of Majority Stake in Caprion Proteomics to Great Point Partners
Thallion Pharmaceuticals Inc. (TSX: TLN) today announced that it has closed the previously announced sale of an 80 percent stake in the Company's wholly-owned proteomics business, Caprion Proteomics GP, to a company formed by Great Point Partners, LLC of Greenwich, Connecticut. Thallion will retain a 20 percent equity interest in the newly created company, to be called Caprion Proteomics Inc., ... (Wed, 11 Jul 2007 12:23:40 GMT)

TLNFF: Closes Sale of 80% Stake in Caprion Proteomics GP
Thallion Pharmaceuticals Inc. (TLNFF) announced that it has closed the previously announced sale of an 80 percent stake in the Company's wholly-owned proteomics business, Caprion Proteomics GP, to a company formed by Great Point Partners, LLC of Greenwich, Connecticut. (Wed, 11 Jul 2007 13:04:48 GMT)

Lumera Announces New Podcast Interviews with Kimberly D.C. Trapp and Dr. Craig Beeson; Next in 2007 Lumera Experts ...
BOTHELL, Wash.----Lumera Corporation , a leader in the emerging field of nanotechnology, announced today the release of its newest podcast interviews with Kimberly D.C. Trapp, Industry Liaison Officer at Lehigh University Center for Optical Technologies as well as an interview with Dr. (Wed, 11 Jul 2007 14:00:00 GMT)

CODA Genomics Raises $7M
Laguna Hills-based CODA Genomics, which is developing technology for protein production, said today that it has raised $7M in a Series C funding round.... (more) (Wed, 11 Jul 2007 14:03:12 GMT)

Synthetic Genomics, ACGT to Sequence Oil Palm Genome for Alternative Energy Clues
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 11 Jul 2007 14:44:18 GMT)

Luminex Corporation Second Quarter Earnings Release Scheduled for July 25, 2007
Luminex Corporation today announced that it expects to report second quarter results on Wednesday, July 25, 2007. (Wed, 11 Jul 2007 15:00:00 GMT)

Korean Research Institute of Bioscience and Biotechnology Licenses ERGO(TM) Genomics Platform to Identify Biological ...
CHICAGO & DAEJEON, South Korea----Korean research Institute of Bioscience and Biotechnology , a world leader in the integrated biotechnology and bioinformatics has licensed the ERGO bioinformatics software developed and maintained by Integrated Genomics. (Wed, 11 Jul 2007 15:48:00 GMT)

Some smokers have genetic predisposition to develop COPD, research shows
WINSTON-SALEM, N.C. – Some people have a genetic variation that makes them more susceptible to chronic obstructive pulmonary disease (COPD) if they smoke tobacco, according to new research from Wake Forest University School of Medicine and colleagues. (Wed, 11 Jul 2007 16:07:57 GMT)

OVP leads two California financings
OVP Venture Partners announced Wednesday that it led two rounds of financings worth a total of $15 million. (Wed, 11 Jul 2007 18:00:15 GMT)

Microchip Biotechnologies, Inc. Secures Key Intellectual Property in Optimized Sample Injection Structures in ...
Microchip Biotechnologies, Inc. is pleased to announce that it has secured key patent rights from Pathwork Diagnostics for sample injection structures in microfluidic separations. (Wed, 11 Jul 2007 19:07:00 GMT)

Equal Footing Foundation to Host Venter Mobile Lab
The following is being issued by Equal Footing Foundation: (Wed, 11 Jul 2007 20:38:59 GMT)

Asiatic buys into US genetic firm
KUALA LUMPUR: Asiatic Development Bhd bought a stake in US genetic research company Synthetic Genomics Inc, and the two set up a joint venture to try and improve the crop’s hardiness. (Wed, 11 Jul 2007 23:51:31 GMT)

NSU makes $70 million bet on biotech lab
South Florida's growing biotech industry has reached Nova Southeastern University, which announced Wednesday it will construct a new $70 million building dedicated to research in the field. (Thu, 12 Jul 2007 01:29:27 GMT)

Nation's Only Lyme Disease Research Center Opens In N.E.
For many, a course of antibiotics will do the trick. But for others, Lyme Disease is more of a chronic problem. (Thu, 12 Jul 2007 03:23:44 GMT)

ASA Announces 2007 Award Winners: Presentations will be made at the Joint Statistical Meetings in Salt Lake City
The American Statistical Association (ASA), the nation's preeminent professional statistical society, today announced the winners of its prestigious annual awards. The winners will be honored on July 31 at the President's Address session of the association's 2007 Joint Statistical Meetings in Salt Lake City. The list of awards and recipients is in the release. (Thu, 12 Jul 2007 07:01:00 GMT)

NSU makes $70 million bet on Davie biotech lab
South Florida's growing biotech industry has reached Nova Southeastern University, which announced Wednesday it will construct a $70 million building dedicated to research in the field. (Thu, 12 Jul 2007 07:24:20 GMT)

12-07-2007: Genting unit in search of gasoline tree
Genting Bhd's plantation unit Asiatic Development Bhd has acquired a stake in US-based Synthetic Genomics Inc for an undisclosed sum as part of a multi-year research and development joint venture (JV) to sequence and analyse the oil palm genome. (Thu, 12 Jul 2007 08:03:43 GMT)

CLC bio releases Molecular Diagnostics Solution
CLC bio just released a molecular diagnostics solution for Multilocus Sequence Typing (MLST). MLST is a portable and precise state-of-the-art technique for typing bacteria and yeast isolates. The development of this new module was motivated by usability studies showing that a typical current-day MLST workflow takes 25 minutes on average. Now, with CLC bio's MLST Module, scientists can conclude ... (Thu, 12 Jul 2007 14:00:22 GMT)

George Mason University's CAP-CLIA Laboratory Utilizes Aushon BioSystems' Array Technology for Individualized and ...
BURLINGTON, Mass.----In a cooperative effort to promote the development of personalized medicine based on reverse-phase protein array technology, Aushon BioSystems has placed a 2470 Arrayer in a CAP-CLIA laboratory established by George Mason University. (Thu, 12 Jul 2007 14:01:00 GMT)

Library Of 3-D Mouse Brain Data Now Online
A multi-institutional consortium including Duke University has created startlingly crisp 3-D microscopic views of tiny mouse brains -- unveiled layer by layer -- by extending the capabilities of conventional magnetic resonance imaging."These images can be more than 100,000 times higher resolution than a clinical MRI scan," said G. Allan Johnson, Duke's Charles E. [click link for full article] (Thu, 12 Jul 2007 14:11:12 GMT)

Test developed for chromosome defect
Empire Genomics LLC is months away from selling its first commercial product -- a test that quickly detects genetic causes of diseases or medical conditions. (Thu, 12 Jul 2007 15:20:46 GMT)

Fish & Richardson Named Top Patent Litigation Firm
IP Law & Business, the leading intellectual property magazine, has for the fourth straight year named the law firm of Fish & Richardson P.C. the top patent litigation firm in the country. (Thu, 12 Jul 2007 15:29:00 GMT)

Aligent licenses tumour study system with platinum complex 12th July 2007
A medical technology company has licensed a method of studying tumours which substitutes a monofunctional platinum complex for enzymes for use in its microarray platform. (Thu, 12 Jul 2007 15:37:44 GMT)

Automated, enzyme-free genotyping directly from human DNA
In recent years, the number of clinically relevant singlenucleotide polymorphisms (SNPs), in combination with linkage disequilibrium information, has increased exponentially. (Thu, 12 Jul 2007 15:52:45 GMT)

Mitrionics and SGI Conduct Bioinformatics Workshop for FPGA-Accelerated Applications at RSSI 2007
Mitrionics(TM), Inc., developer of the Mitrion(TM) Software Acceleration Platform and the Mitrion Virtual Processor, today announced that its Co-Founder and Chief Technology Officer Stefan Möhl, along with SGI's Principal Engineer Matthias Fouquet-Lapar, will be conducting an all-day Bioinformatics Workshop featuring its Mitrion-accelerated NCBI BLAST application at the Reconfigurable Systems ... (Thu, 12 Jul 2007 16:03:00 GMT)

Six research teams receive IRDF funding
Six research teams have been awarded seed funding in the May funding cycle of the UB 2020 Interdisciplinary Research Development Fund (IRDF). (Thu, 12 Jul 2007 18:06:46 GMT)

Thallion Announces 2007 Second Quarter Results
Thallion Pharmaceuticals Inc. today announced its operational and financial results for the 2007 second quarter which ended on May 31, 2007. (Thu, 12 Jul 2007 20:00:00 GMT)

BioDiscovery Releases NEXUS CGH for Analysis and Visualization of DNA Copy Number Data
BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research announced today the release of NEXUS CGH, a unique and novel tool for analysis of array CGH-based data from multi-array experiments supporting any platform, including Agilent, Nimblegen, Affymetrix, Illumina, Empire Genomics, and most home-spotted arrays. (Fri, 13 Jul 2007 07:01:00 GMT)

University honours impact-making top achievers
FROM the railways to the space station, from cartoons to opera, the University of Leeds has honoured eight people who have each made a major impact in their field of expertise. (13/07/2007 07:51:10) (Fri, 13 Jul 2007 07:13:24 GMT)

Calhoun starting biotech program
When Donna Pressnell returned to college, she wanted a major in which she could help people. Now, she thinks she has found a program that will enable her to help her disabled daughter. (Fri, 13 Jul 2007 10:22:06 GMT)

Power3 Medical Retains The Investor Relations Group of New York
HOUSTON----Power3 Medical Products, Inc. , a leading proteomics company specializing in the development and commercialization of early detection diagnostic tests for breast cancer and neurodegenerative disease, has retained The Investor Relations Group, Inc. , based in New York City, to serve as its investor relations and corporate communications firm. (Fri, 13 Jul 2007 13:21:00 GMT)

South Korean Bioscience Institute Uses Integrated Genomics' ERGO Software
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Fri, 13 Jul 2007 14:14:27 GMT)

Korean Research Institute Of Bioscience And Biotechnology Licenses ERGO Genomics Platform To Identify Biological ...
Korean research Institute of Bioscience and Biotechnology (KRIBB), a leader in the integrated biotechnology and bioinformatics has licensed the ERGO bioinformatics software developed and maintained by Integrated Genomics (Fri, 13 Jul 2007 15:04:31 GMT)

New DNA Sequencing Technology Enables Insurance Companies and Defense Lawyers to Weed Out Fraud in Class-Action Suits
WHAT: Bruce S. Gillis, M.D., M.P.H., a medical toxicologist and CEO of the research group, The Cytokine Institute, will present a tutorial on a new genomics-based technology, msds1. (Fri, 13 Jul 2007 17:57:00 GMT)

Researchers Solve Protein from Pathogen Associated With CF and TB
The structure of a novel protein in the bacterium that is the most persistent pathogen in cystic fibrosis (CF) patients has been solved. The discovery unlocks key information that may help lead to the design of antibiotics that will help prevent infection in Cystic Fibrosis and Tuberculosis patients. (Fri, 13 Jul 2007 19:28:22 GMT)

CLC Bio Releases A Portable And Precise State-Of-The-Art Technique For Typing Bacteria And Yeast Isolates
CLC bio just released a molecular diagnostics solution for Multilocus Sequence Typing (MLST). MLST is a portable and precise state-of-the-art technique for typing bacteria and yeast isolates. The development of this new module was motivated by usability studies showing that a typical current-day MLST workflow takes 25 minutes on average. [click link for full article] (Sat, 14 Jul 2007 08:13:06 GMT)

Area firm plans to market genetic tests for illnesses
When it comes to health, our destiny is in our genes. (Sat, 14 Jul 2007 10:48:58 GMT)

Innovative Project To Develop Cancer Vaccine
Biodesign Institute researchers have received nearly $9 million in grants to develop a preventive vaccine against cancer.Stephen Albert Johnston, PhD, director of the institute's Center for Innovations in Medicine, will focus his research project on breast cancer. Johnston is one of only two recipients in the nation bestowed with a five-year, $7. [click link for full article] (Sat, 14 Jul 2007 16:11:16 GMT)

Outwitting pesky parasites
MADISON, WI, July 15, 2007 - Across the southern United States, an invisible, yet deadly parasite known as the root-knot nematode is crippling soybean crops. (Sun, 15 Jul 2007 04:10:12 GMT)

Outwitting Pesky Parasites: Researchers Find a Shortcut for Screening Resistant Soybean Crops
To stop the root-knot nematode from destroying soybean crops, plant breeders must move quickly. Scientists from the University of Georgia have discovered faster and less expensive way to screen resistant soybean crops. (Sun, 15 Jul 2007 04:28:22 GMT)

DNA pinpoints pooch pedigrees
Rudi's ears look like they can pick up signals from other planets. They stand at attention, fringed by fine strands of fur like so many sensitive antennae. (Sun, 15 Jul 2007 08:45:49 GMT)

Sorenson's goal for DNA research? World peace
Utah's richest man can't sit still for a TV program or a movie because he gets lost in the most simple plot. Yet, ideas gush from James LeVoy Sorenson like music from a savant. (Sun, 15 Jul 2007 09:20:09 GMT)

Gene discovered for type 1 diabetes in children
Pediatrics researchers at The Children's Hospital of Philadelphia and McGill University in Montreal have identified a gene variant that raises a child's risk for type 1 diabetes, formerly called juvenile diabetes. As investigators continue to pinpoint genes contributing to diabetes, they have their eyes on providing a scientific basis for designing better treatments and preventive measures for ... (Sun, 15 Jul 2007 17:07:57 GMT)

Scientists identify key gene in type 1 diabetes
WASHINGTON (Reuters) - Scientists have pinpointed an important gene involved in increasing a child's risk for type 1 diabetes, a discovery they said may lead to a way to prevent the development of the disease. (Sun, 15 Jul 2007 17:26:38 GMT)

Genetic Predisposition To Develop COPD Found In Some Smokers
Some people have a genetic variation that makes them more susceptible to chronic obstructive pulmonary disease (COPD) if they smoke tobacco, according to new research from Wake Forest University School of Medicine and colleagues."The genetic variant we studied seemed harmless on its own," said Alireza Sadeghnejad, M.D., Ph.D., lead author. [click link for full article] (Sun, 15 Jul 2007 18:19:58 GMT)

News: Uncovered: New Gene Linked to Type 1 Diabetes in Children
A research team has identified a new gene that likely affects a child's chances of developing type 1 diabetes. (Sun, 15 Jul 2007 19:15:35 GMT)

Luminex Corporation Names Douglas C. Bryant as Executive Vice President and Chief Operating Officer
Luminex Corporation a developer and manufacturer of proprietary life science and biological testing technologies, today announced that Douglas C. Bryant has been named Executive Vice President and Chief Operating Officer effective Monday, July 16, 2007. (Sun, 15 Jul 2007 22:00:00 GMT)

Luminex Corporation Names Douglas C. Bryant as Executive Vice President and Chief Operating Officer
AUSTIN, Texas, July 15 /PRNewswire-FirstCall/ -- Luminex Corporation ( Nachrichten ) a developer and manufacturer of proprietary life science and biological testing technologies, today announced that Douglas C. Bryant has been named Executive Vice President and Chief Operating Officer effective Monday, July 16, 2007. Mr. Bryant will oversee all elements of the Company's operations, including ... (Sun, 15 Jul 2007 22:20:37 GMT)

Researchers Determine Structure Of Protein From Pathogen Associated With Cystic Fibrosis And Tuberculosis
The structure of a novel protein in the bacterium that is the most persistent pathogen in cystic fibrosis patients has been solved. (Mon, 16 Jul 2007 04:04:25 GMT)

Current Issue:
The list of environmental causes of cancer increases almost every day, growing to include extraneous products we such as tobacco and hair dyes, to products we can't seem to avoid such as gasoline and pesticides. (Mon, 16 Jul 2007 04:57:20 GMT)

Bio in the 'burbs
Two years after the two founders of Agrivida Inc. moved into a small lab space in Cambridge, the now 13-person agricultural biotech company has outgrown its lab and plans to move north next month into larger quarters in the city of Medford, according to co-founder Jeremy Johnson. (Mon, 16 Jul 2007 05:52:12 GMT)

Boffins identify gene for Type 1 diabetes in kids
London, July 16 (ANI): Canadian researchers have identified a gene variant that raises a child's chances of developing type 1 diabetes, previously known as juvenile diabetes. The research conducted by paediatricians at The Children's Hospital of Philadelphia and McGill University in Montreal has added a new gene information to the already known four genes. "The genotyping technology ... (Mon, 16 Jul 2007 06:32:25 GMT)

Immune Targeting Systems (ITS) Ltd. Concludes a Series-A Funding Round of GBP 3.5M (EUR 5.2M)
LONDON----Immune Targeting Systems Limited , the company developing synthetic vaccines for mutating viruses, today announced it had closed its series-A equity funding round for GBP 3.5m . (Mon, 16 Jul 2007 07:00:00 GMT)

New Type 1 Diabetes Gene Found In Children
A team of scientists in the US and Canada have discovered a gene variant that is thought to increase a child's risk for type 1 diabetes.The study is published in the advanced online publication of the journal Nature.Type 1 diabetes used to be called juvenile diabetes because it mostly begins in childhood. [click link for full article] (Mon, 16 Jul 2007 07:12:26 GMT)

CombiMatrix Molecular Diagnostics Launches Next Enhanced Version of Its Constitutional Genetic Array Test
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that its CombiMatrix group's subsidiary, Combimatrix Molecular Diagnostics , has completed the clinical validation of and has launched the third version of its Constitutional Array Genetic Test . (Mon, 16 Jul 2007 10:00:00 GMT)

Acacia Technologies Enters into License Agreement with CMS Products
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that its Disc Link Corporation subsidiary, which is part of its Acacia Technologies group, a leader in technology licensing, has entered into a license agreement with CMS Products, Inc. covering patents relating to portable storage devices with links. (Mon, 16 Jul 2007 10:01:00 GMT)

Acacia Technologies Enters into Retroactive License with Lowe's Home Centers, Inc. Concerning Credit Card Fraud ...
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that Financial Systems Innovation LLC, a wholly owned subsidiary of the Acacia Technologies group, a leader in technology licensing, has entered into a retroactive license with Lowe's Home Centers, Inc. concerning certain patent rights that apply to credit card fraud protection technology. (Mon, 16 Jul 2007 10:02:00 GMT)

Acacia Technologies Enters into Retroactive License with Lowe's Home Centers, Inc. Concerning Credit Card Fraud ...
NEWPORT BEACH, Calif., (Mon, 16 Jul 2007 11:23:20 GMT)

Acacia Technologies Enters into License Agreement with CMS Products
NEWPORT BEACH, Calif., (Mon, 16 Jul 2007 11:38:19 GMT)

Affymetrix Clinical Services Laboratory and DOCRO Join Forces to Accelerate the Commercialization of In Vitro ...
Affymetrix Inc. ( Nachrichten ) (Nasdaq:AFFX) announced today that the Affymetrix Clinical Services Laboratory (ACSL) has signed a co-marketing agreement with DOCRO Inc., a leading contract research organization (CRO) that specializes in the commercialization of in vitro diagnostic (IVD) biomarker technologies. (Mon, 16 Jul 2007 12:23:38 GMT)

Lipomics Technologies to Partner With UC San Diego in Insulin Resistance and Weight Loss Research
Lipomics Technologies, Inc., a privately held company that specializes in clinical diagnostic development, announced today that it has entered into an agreement with The University of California, San Diego. The collaboration will focus on clinical investigations aimed at identifying mechanisms underlying the pathogenesis of non-insulin dependent diabetes mellitus (NIDDM), obesity, and other ... (Mon, 16 Jul 2007 12:54:29 GMT)

Thermo Fisher Scientific adds FAIMS Capability to Ion Trap Mass Spectrometers: Precise and ...
Chromatography and Mass Spectrometry June 06 2007 -- Thermo Fisher Scientific, the world leader in serving science, announces that the Thermo Scientific FAIMS (high-Field Asymmetric waveform Ion Mobility Spectrometry) interface is now available for the Thermo Scientific industry-leading family of ion trap mass spectrometers. The FAIMS capability eliminates interferences and significantly ... (Mon, 16 Jul 2007 12:57:06 GMT)

University of Arizona Researchers Speed Time to Results With SGI Solutions
To replace current high-performance compute systems with systems of higher capacity and more capability, the Center for Computing and Information Technology at The University of Arizona , working with the University's HPC Task Force, selected SGI technology as a university-wide CCIT Research Computing resource. (Mon, 16 Jul 2007 13:00:00 GMT)

Monsanto Is Ready to Round Up the Bulls
This chemical company, along with its sector, is charging higher and has an excellent technical setup. (Mon, 16 Jul 2007 13:22:58 GMT)

Aperio Launches Advanced Digital Pathology Solution for Tissue Microarray Analysis and Research
VISTA, Calif.----Aperio Technologies, Inc., the leading provider of digital pathology systems and services for the healthcare and life sciences industry, has launched TMALab II, the latest release of the company's web-based digital pathology information management system, built specifically for researchers who use Tissue Microarrays . (Mon, 16 Jul 2007 13:30:00 GMT)

Ag Chem Stocks Galloping Upward
Monsanto, along with its sector, is charging higher and has an excellent technical setup. (Mon, 16 Jul 2007 13:52:58 GMT)

Boffins identify gene for Type 1 diabetes in kids
London, July 16 : Canadian researchers have identified a gene variant that raises a child's chances of developing type 1 diabetes, previously known as juvenile diabetes. (Mon, 16 Jul 2007 14:29:18 GMT)

Breakthrough in Type 1 Diabetes in Children
Type 1 diabetes occurs when the immune system destroys cells in the pancreas that produce insulin, the hormone that regulates blood glucose. (Mon, 16 Jul 2007 14:32:41 GMT)

D-Lib Magazine July/August 2007
To help faculty, researchers, and students in the life sciences discover common interests and make connections, the Cornell University Library has created a virtual life sciences community that uses an entity-relationship ontology model to organize and present information on people, research, and education activities. (Mon, 16 Jul 2007 16:09:30 GMT)

Ginormous Investment Opportunities Abound
Big opportunities await patient investors in nanotech, cleantech, and robotics. (Mon, 16 Jul 2007 16:24:37 GMT)

Key gene identified in type 1 diabetes
WASHINGTON - Scientists have pinpointed an important gene involved in increasing a child’s risk for type 1 diabetes, a discovery they said may lead to a way to prevent the development of the disease. (Mon, 16 Jul 2007 16:28:04 GMT)

A decisive step toward a cure for insulin dependent diabetes
Montreal, July 15, 2007 – A diagnosis of type I diabetes means a life sentence of medical follow-up. While treatments have become simpler and less restrictive in recent years, they are still a burden, especially for young patients. (Mon, 16 Jul 2007 16:38:07 GMT)

Gene Discovered For Type 1 Diabetes In Children
Pediatrics researchers at The Children's Hospital of Philadelphia and McGill University in Montreal have identified a gene variant that raises a child's risk for type 1 diabetes, formerly called juvenile diabetes. As investigators continue to pinpoint genes contributing to diabetes, they have their eyes on providing a scientific basis for designing better treatments and preventive measures for ... (Mon, 16 Jul 2007 18:18:44 GMT)

Empire Genomics Licenses Roswell Park's Genomics Libraries, Accesses Labs, Personnel
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Mon, 16 Jul 2007 19:44:29 GMT)

Applied Biosystems Group and Celera Group Fourth Quarter and Fiscal 2007 Financial Results and Conference Call ...
NORWALK, Conn.----Applera Corporation announced today that it will issue fiscal 2007 fourth quarter and full year results for its Applied Biosystems Group and Celera Group on Wednesday, July 25, 2007. (Mon, 16 Jul 2007 21:30:00 GMT)

Applied Biosystems Group and Celera Group Fourth Quarter and Fiscal 2007 Financial Results and Conference Call ...
Applera Corporation announced today that it will issue fiscal 2007 fourth quarter and full year results for its Applied Biosystems Group ( Nachrichten ) (NYSE:ABI) and Celera Group ( Nachrichten ) (NYSE:CRA) on Wednesday, July 25, 2007. Results are scheduled for release before the opening of trading on the New York Stock Exchange. (Mon, 16 Jul 2007 21:35:44 GMT)

New funding committed to Greenhouse Gas research
An extra $1.2 million a year has been committed for research by the Pastoral Greenhouse Gas Consortium (PGgRC) increasing its investment to $5m each year for the next five years, PGgRC Chairman, Mark Leslie announced today. (Mon, 16 Jul 2007 22:38:46 GMT)

Researchers determine structure of protein from pathogen associated with cystic fibrosis
The structure of a novel protein in the bacterium that is the most persistent pathogen in cystic fibrosis (CF) patients has been solved. (Mon, 16 Jul 2007 23:09:14 GMT)

Diabetes gene found
NEW DELHI: In a discovery that could help prevent children from becoming diabetic, scientists have found a gene that increases a child's risk for type 1 diabetes. (Mon, 16 Jul 2007 23:18:37 GMT)

New genomics-based technology
Bruce S. Gillis, M.D., M.P.H., a medical toxicologist and CEO of the research group, The Cytokine Institute, will present a tutorial on a new genomics-based technology, msds1(TM). (Mon, 16 Jul 2007 23:25:14 GMT)

EuroBiO 2007 in Lille, France - Sept 26th-28th
EuroBiO 2007 will be back in Lille from September 26th to 28th and is again positioning itself as the leading platform for dialogue and networking between stakeholders in biotech, bioscience and the bioindustry. (Tue, 17 Jul 2007 00:09:00 GMT)

Gene detectives discover culprit for type 1 diabetes
Researchers at the Children's Hospital of Philadelphia and McGill University in Montreal have discovered a gene they believe is the culprit in a person developing type 1 diabetes. (Tue, 17 Jul 2007 01:25:34 GMT)

Celestial Labs shares rise 16.7 percent on debut
MUMBAI, July 17 - Shares in bio-informatics service provider Celestial Labs Ltd. made their debut at 70 rupees on Tuesday, 16.7 percent higher than the issue price of 60 rupees. (Tue, 17 Jul 2007 04:29:34 GMT)

Nonprofit is foundation for clinical trials' success
Clinical trials are as crucial to the development of new medicines and therapies as the discovery of a new compound. (Tue, 17 Jul 2007 06:52:57 GMT)

Proteomics Market to Cross $3.6 Billion by 2010, According to New Report by Global Industry Analysts, Inc.
Proteomics has risen from the point where genomics studies plateaued. The research stream has become the current spotlight for pharmaceutical and biotechnology companies as it opens new roads to precision medication and customized diagnosis and treatment. Global proteomics market is projected to cross US$3.6 billion by 2010. (Tue, 17 Jul 2007 07:01:00 GMT)

DGAP-News: NascaCell Technologies AG english
NascaCell Technologies AG receives additional funding from the BioChance Plus program Corporate News transmitted by DGAP - a company of EquityStory AG. (Tue, 17 Jul 2007 07:30:30 GMT)

CampusMint™, The First Mobile Promotions Application Geared Towards College Students, Launches
CampusMint™, the first mobile promotions application geared towards college students, launches.College students can simply show their cellphones to receive discounts at their favorite stores and restaurants. (PRWeb Jul 17, 2007) Post Comment:Trackback URL: http://www.prweb.com/pingpr.ph (Tue, 17 Jul 2007 07:31:30 GMT)

Acacia Technologies Licenses Credit Card Fraud Protection Technology to J. Crew
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that Financial Systems Innovation LLC, a wholly owned subsidiary of the Acacia Technologies group, a leader in technology licensing, has entered into a release and covenant not to sue covering a patent that applies to credit card fraud protection technology with J. (Tue, 17 Jul 2007 10:00:00 GMT)

Rosetta Genomics Announces Expansion of its Research Facility
Rosetta Genomics Ltd , a leading microRNA company, announced today the expansion of its Israeli research facility. The company is adding the new laboratories to its state-of-the-art facilities in order to meet its research and development needs for its microRNA-based diagnostic programs. (Tue, 17 Jul 2007 10:16:00 GMT)

Dr. Richard Brennan Joins GeneGo as Director of Toxicology
GeneGo, Inc., the leading provider of databases, software and services in systems biology, today announced the appointment of Dr. Richard Brennan as Director of Toxicology. Dr. Brennan is a Diplomate of the American Board of Toxicology and brings extensive experience in the pharmaceutical and biotechnology industry, with particular expertise in molecular toxicology and toxicogenomics. (Tue, 17 Jul 2007 11:00:00 GMT)

Quidel Corporation Announces Exclusive Licenses to Molecular Antiviral Resistance and Detection Technology for Influenza
SAN DIEGO----Quidel Corporation , a leading provider of rapid point-of-care diagnostic tests, today announced exclusive, worldwide licenses to the antiviral resistance microarray-based influenza detection technology and to the microarray-based influenza B detection technology , both developed by scientists at the University of Colorado at Boulder in close collaboration with the U.S. (Tue, 17 Jul 2007 11:00:00 GMT)

SRI International Awarded DARPA Subcontract to Accelerate Vaccine Manufacturing Process
MENLO PARK, Calif.----SRI International, an independent nonprofit research and development organization, announced today that it will collaborate with Neugenesis Corporation, a biotechnology company developing complex protein biotherapeutics, to develop technologies for the rapid manufacturing of vaccines and drugs. (Tue, 17 Jul 2007 11:01:00 GMT)

Quidel Corporation Announces Exclusive Licenses to Molecular Antiviral Resistance and Detection Technology for Influenza
Quidel Corporation ( Nachrichten ) (NASDAQ:QDEL) , a leading provider of rapid point-of-care diagnostic tests, today announced exclusive, worldwide licenses to the antiviral resistance microarray-based influenza detection technology (AVR-Chip) and to the microarray-based influenza B detection technology (BChip), both developed by scientists at the University of Colorado at Boulder (CU-Boulder) in ... (Tue, 17 Jul 2007 11:08:50 GMT)

Luminex Corporation Unveils FlexMAP 3D(TM), the Next Generation Instrument, at AACC
AUSTIN, Texas, July 17 /PRNewswire-FirstCall/ -- Luminex Corporation ( Nachrichten ), the world leader in multiplexed solutions, will unveil FlexMAP 3D(TM), its next generation bead-based multiplexing system, today at the American Association for Clinical Chemistry (AACC) Annual Meeting in San Diego. (Tue, 17 Jul 2007 11:09:11 GMT)

Acacia Technologies Licenses Credit Card Fraud Protection Technology to J. Crew
NEWPORT BEACH, Calif., (Tue, 17 Jul 2007 11:38:30 GMT)

Affymetrix and Children's Research Institute Form Five-year Strategic Alliance
SANTA CLARA, Calif. & MILWAUKEE----Affymetrix Inc. and Children's Research Institute, a not-for-profit medical research member organization of Children's Hospital and Health System affiliated with Medical College of Wisconsin, announced today that they have entered into a five-year strategic alliance. (Tue, 17 Jul 2007 12:00:00 GMT)

Nanogen Begins Shipment of Congestive Heart Failure Product
SAN DIEGO----Nanogen, Inc. , developer of advanced diagnostic products, announced today that it has begun shipment of its congestive heart failure product, the StatusFirst CHF NT-proBNP rapid test. (Tue, 17 Jul 2007 12:00:00 GMT)

Matritech to Report Second Quarter 2007 Financial Results on July 31, 2007
NEWTON, Mass.----Matritech announced today that it will release its second quarter 2007 earnings results before market opening on July 31, 2007. The company has scheduled a conference call at 8:30 a.m. that day to discuss the results and provide a company update. (Tue, 17 Jul 2007 13:00:00 GMT)

SRI International Awarded DARPA Subcontract To Accelerate Vaccine Manufacturing Process
SRI International, an independent nonprofit research and development organization, announced today that it will collaborate with Neugenesis Corporation, a biotechnology company developing complex protein biotherapeutics, to develop technologies for the rapid manufacturing of vaccines and drugs (Tue, 17 Jul 2007 13:04:21 GMT)

The UAB heads a European research project on proteases and pathological processes
A research group of the UAB Institute of Biotechnology and Biomedicine and the UAB Department of Biochemistry and Molecular Biology, directed by Francesc Xavier Avilés, is the coordinator of a European project aimed at studying proteases with fluorescent molecules that allow their monitoring in healthy and pathological situations. (Tue, 17 Jul 2007 13:10:13 GMT)

Future Design Of Antibiotic To Help Prevent Infection In Cystic Fibrosis And TB Patients
The structure of a novel protein in the bacterium that is the most persistent pathogen in cystic fibrosis (CF) patients has been solved.Hauptman-Woodward Institute scientists Dr. Andrew Gulick, Eric Drake and Dr. [click link for full article] (Tue, 17 Jul 2007 14:11:16 GMT)

George Mason to Combine Proteomics and Biodefense Centers to Study Infectious Diseases
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 17 Jul 2007 14:44:17 GMT)

Southern India Plans New Genomics Research Center
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 17 Jul 2007 14:44:57 GMT)

Madison, Wisconsin July 17, 2007
Across the southern United States, an invisible, yet deadly parasite known as the root-knot nematode is crippling soybean crops. (Tue, 17 Jul 2007 15:39:29 GMT)

Aberdeen, Idaho July 16, 2007 Jianli Chen, a research scientist in wheat breeding and genetics at Virginia Tech, has ...
College of Agricultural and Life Sciences as its wheat breeder in Aberdeen. Chen earned her Ph.D. in 2005 in plant genetics and breeding at Virginia Tech, where she led a program focusing on breeding and genetics of wheat Fusarium head blight disease. (Tue, 17 Jul 2007 15:40:39 GMT)

Countdown to a synthetic lifeform
As the first genome "transplant" is performed, scientists say it is only a matter of time before a truly artificial lifeform is created (Tue, 17 Jul 2007 17:29:05 GMT)

Arutz 7 TV
(IsraelNN.com) An eight-man Israeli start-up named Immunarray is working on a simple and inexpensive blood test called the I-Chip, which promises to diagnose lung cancer, and a host of other diseases, even at the earliest stages. (Tue, 17 Jul 2007 18:28:16 GMT)

Affymetrix in 5-Year Development Deal
Affymetrix Inc. said Tuesday it signed a five-year collaboration agreement with Children's Research Institute to develop tests for common and complex diseases affecting children. (Tue, 17 Jul 2007 18:29:28 GMT)

Rosetta Genomics Expands Research Lab in Israel
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 17 Jul 2007 18:59:57 GMT)

Invitrogen and Biocon Announce Exclusive Agreement to Supply New Source of Insulin to Global Cell Culture Market
Invitrogen Corporation ( Nachrichten ) (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, has signed an exclusive agreement with Biocon Limited to market pharmaceutical-grade insulin to the global cell culture market. (Tue, 17 Jul 2007 21:05:34 GMT)

Major Alzheimer's discovery in Valley
Every 72 seconds, someone is diagnosed with Alzheimer's disease. One in eight of us at age 65 or older will develop the disease. But there is hope. A discovery made by researchers here in the Valley is a major breakthrough in preventing and treating the deadly disease. (Wed, 18 Jul 2007 00:07:55 GMT)

New hope for insulin dependent diabetes cure
A diagnosis of type I diabetes means a life sentence of medical follow-up. (Wed, 18 Jul 2007 01:09:35 GMT)

Constella Group Announces Partnership with TCG Lifesciences
Constella Group, a leading global provider of professional health services, today announced that it has entered into a partnership with TCG Lifesciences, an Indian-based contract drug discovery and drug development company. As part of the non-exclusive relationship, Constella and TCG Lifesciences will jointly promote their contract services and identify and promote business opportunities across ... (Wed, 18 Jul 2007 04:28:00 GMT)

$10.8 million boost to Waikato research funding
University of Waikato researchers in computer science and engineering have received almost $10.8 million in the latest Foundation for Research, Science and Technology funding round announced today. (Wed, 18 Jul 2007 04:38:06 GMT)

Genetics Discovery Should Improve Treatments And Preventive Measures For Type 1 Diabetes In Children
Pediatrics researchers at The Children's Hospital of Philadelphia and McGill University in Montreal have identified a gene variant that raises a child's risk for type 1 diabetes, formerly called juvenile diabetes. [click link for full article] (Wed, 18 Jul 2007 08:11:09 GMT)

Previous 1 2 3 4 Next